The Nuclear Energy Corporation of SA (Necsa) group of companies are in crisis and must be “reshaped” now that the nuclear build programme looks likely to be pushed out into the distant future, Rob Adam, the new chair of the board of directors, told MPs on Tuesday. Necsa made a loss over the past two years, as did subsidiary Pelchem, which manufactures fluorochemicals . Another subsidiary, NTP Radioisotopes, which manufactures products for nuclear medicine, was profit-making. Necsa CEO Kelvin Kemm was suspended and the board was replaced by energy minister Jeff Radebe in November. Adam, a previous CEO of Necsa, told parliament’s committee on energy that, with the exception of NTP Radioscopes, the companies of the group should be “reshaped”. “For the best part of a decade and a half there has been talk of a new nuclear build. Necsa has been asked to retain nuclear capabilities over this period and support these by looking for commercial activities. But there comes a point where commer...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now